Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism

S. H. Lin, S. D. Shieh, S. H. Chyr, K. C. Lu, Y. F. Lin, L. K. Diang, T. C. Chou, Y. A. Ding

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background. To investigate the effect of the reversal of hyperparathyroidism on platelet intracellular free calcium ([Ca 2+](i)) by pharmacologial parathyroidectomy with intravenous calcitriol in uremic patients with secondary hyperparathyroidism (2°HPT). Methods. Serum concentrations of intact parathyroid hormone (I-PTH) were measured by two-site immunometric assay, and platelet [Ca 2+](i) was assessed using the fluorescent indicator fura-2. Fifteen hemodialysis patients with 2°HPT and serum I-PTH 4 times greater than the normal upper limits, were selected for treatment with intravenous calcitriol 1 μg thrice weekly for one month. Results. An increase of serum I-PTH (449.17 ± 52.35 vs 32.52 ± 1.95 pg/ml) and elevated platelet [Ca 2+](i) (139.49 ± 8.78 vs 74.70 ± 6.48 nM/L) was observed in uremic patients with 2°HPT. Serum I-PTH levels were significantly correlated with platelet [Ca 2+](i) in uremic patients with 2°HPT (r = 0.736, p = 0.002). The serum I-PTH levels decreased from 449.17 ± 52.35 to 221.27 ± 35.66 pg/ml (p <0.001) and platelet [Ca 2+](i) fell from 139.49 ± 8.78 to 97.86 ± 7.25 nM/L (p <0.001) after treatment. Fall in platelet [Ca 2+](i) was related to concomitant reduction in PTH levels (r = 0.572, p = 0.026). Conclusions. It was concluded that an increase in cytosolic calcium in uremia may be at least in part induced by PTH. Besides, intravenous calcitriol can provide an effective way to suppress elevated serum I-PTH and attenuate platelet free calcium in uremia with 2°HPT.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalChinese Medical Journal (Taipei)
Volume54
Issue number4
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Secondary Hyperparathyroidism
Calcitriol
Renal Dialysis
Parathyroid Hormone
Blood Platelets
Calcium
Serum
Uremia
Parathyroidectomy
Hyperparathyroidism
Fura-2
Therapeutics

Keywords

  • calcitriol
  • platelet calcium
  • secondary hyperparathyroidism
  • uremia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism. / Lin, S. H.; Shieh, S. D.; Chyr, S. H.; Lu, K. C.; Lin, Y. F.; Diang, L. K.; Chou, T. C.; Ding, Y. A.

In: Chinese Medical Journal (Taipei), Vol. 54, No. 4, 1994, p. 240-245.

Research output: Contribution to journalArticle

Lin, S. H. ; Shieh, S. D. ; Chyr, S. H. ; Lu, K. C. ; Lin, Y. F. ; Diang, L. K. ; Chou, T. C. ; Ding, Y. A. / Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism. In: Chinese Medical Journal (Taipei). 1994 ; Vol. 54, No. 4. pp. 240-245.
@article{3c656bac4b854a9a9be5d36bd9e22baf,
title = "Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism",
abstract = "Background. To investigate the effect of the reversal of hyperparathyroidism on platelet intracellular free calcium ([Ca 2+](i)) by pharmacologial parathyroidectomy with intravenous calcitriol in uremic patients with secondary hyperparathyroidism (2°HPT). Methods. Serum concentrations of intact parathyroid hormone (I-PTH) were measured by two-site immunometric assay, and platelet [Ca 2+](i) was assessed using the fluorescent indicator fura-2. Fifteen hemodialysis patients with 2°HPT and serum I-PTH 4 times greater than the normal upper limits, were selected for treatment with intravenous calcitriol 1 μg thrice weekly for one month. Results. An increase of serum I-PTH (449.17 ± 52.35 vs 32.52 ± 1.95 pg/ml) and elevated platelet [Ca 2+](i) (139.49 ± 8.78 vs 74.70 ± 6.48 nM/L) was observed in uremic patients with 2°HPT. Serum I-PTH levels were significantly correlated with platelet [Ca 2+](i) in uremic patients with 2°HPT (r = 0.736, p = 0.002). The serum I-PTH levels decreased from 449.17 ± 52.35 to 221.27 ± 35.66 pg/ml (p <0.001) and platelet [Ca 2+](i) fell from 139.49 ± 8.78 to 97.86 ± 7.25 nM/L (p <0.001) after treatment. Fall in platelet [Ca 2+](i) was related to concomitant reduction in PTH levels (r = 0.572, p = 0.026). Conclusions. It was concluded that an increase in cytosolic calcium in uremia may be at least in part induced by PTH. Besides, intravenous calcitriol can provide an effective way to suppress elevated serum I-PTH and attenuate platelet free calcium in uremia with 2°HPT.",
keywords = "calcitriol, platelet calcium, secondary hyperparathyroidism, uremia",
author = "Lin, {S. H.} and Shieh, {S. D.} and Chyr, {S. H.} and Lu, {K. C.} and Lin, {Y. F.} and Diang, {L. K.} and Chou, {T. C.} and Ding, {Y. A.}",
year = "1994",
language = "English",
volume = "54",
pages = "240--245",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism

AU - Lin, S. H.

AU - Shieh, S. D.

AU - Chyr, S. H.

AU - Lu, K. C.

AU - Lin, Y. F.

AU - Diang, L. K.

AU - Chou, T. C.

AU - Ding, Y. A.

PY - 1994

Y1 - 1994

N2 - Background. To investigate the effect of the reversal of hyperparathyroidism on platelet intracellular free calcium ([Ca 2+](i)) by pharmacologial parathyroidectomy with intravenous calcitriol in uremic patients with secondary hyperparathyroidism (2°HPT). Methods. Serum concentrations of intact parathyroid hormone (I-PTH) were measured by two-site immunometric assay, and platelet [Ca 2+](i) was assessed using the fluorescent indicator fura-2. Fifteen hemodialysis patients with 2°HPT and serum I-PTH 4 times greater than the normal upper limits, were selected for treatment with intravenous calcitriol 1 μg thrice weekly for one month. Results. An increase of serum I-PTH (449.17 ± 52.35 vs 32.52 ± 1.95 pg/ml) and elevated platelet [Ca 2+](i) (139.49 ± 8.78 vs 74.70 ± 6.48 nM/L) was observed in uremic patients with 2°HPT. Serum I-PTH levels were significantly correlated with platelet [Ca 2+](i) in uremic patients with 2°HPT (r = 0.736, p = 0.002). The serum I-PTH levels decreased from 449.17 ± 52.35 to 221.27 ± 35.66 pg/ml (p <0.001) and platelet [Ca 2+](i) fell from 139.49 ± 8.78 to 97.86 ± 7.25 nM/L (p <0.001) after treatment. Fall in platelet [Ca 2+](i) was related to concomitant reduction in PTH levels (r = 0.572, p = 0.026). Conclusions. It was concluded that an increase in cytosolic calcium in uremia may be at least in part induced by PTH. Besides, intravenous calcitriol can provide an effective way to suppress elevated serum I-PTH and attenuate platelet free calcium in uremia with 2°HPT.

AB - Background. To investigate the effect of the reversal of hyperparathyroidism on platelet intracellular free calcium ([Ca 2+](i)) by pharmacologial parathyroidectomy with intravenous calcitriol in uremic patients with secondary hyperparathyroidism (2°HPT). Methods. Serum concentrations of intact parathyroid hormone (I-PTH) were measured by two-site immunometric assay, and platelet [Ca 2+](i) was assessed using the fluorescent indicator fura-2. Fifteen hemodialysis patients with 2°HPT and serum I-PTH 4 times greater than the normal upper limits, were selected for treatment with intravenous calcitriol 1 μg thrice weekly for one month. Results. An increase of serum I-PTH (449.17 ± 52.35 vs 32.52 ± 1.95 pg/ml) and elevated platelet [Ca 2+](i) (139.49 ± 8.78 vs 74.70 ± 6.48 nM/L) was observed in uremic patients with 2°HPT. Serum I-PTH levels were significantly correlated with platelet [Ca 2+](i) in uremic patients with 2°HPT (r = 0.736, p = 0.002). The serum I-PTH levels decreased from 449.17 ± 52.35 to 221.27 ± 35.66 pg/ml (p <0.001) and platelet [Ca 2+](i) fell from 139.49 ± 8.78 to 97.86 ± 7.25 nM/L (p <0.001) after treatment. Fall in platelet [Ca 2+](i) was related to concomitant reduction in PTH levels (r = 0.572, p = 0.026). Conclusions. It was concluded that an increase in cytosolic calcium in uremia may be at least in part induced by PTH. Besides, intravenous calcitriol can provide an effective way to suppress elevated serum I-PTH and attenuate platelet free calcium in uremia with 2°HPT.

KW - calcitriol

KW - platelet calcium

KW - secondary hyperparathyroidism

KW - uremia

UR - http://www.scopus.com/inward/record.url?scp=0028033743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028033743&partnerID=8YFLogxK

M3 - Article

C2 - 7982134

AN - SCOPUS:0028033743

VL - 54

SP - 240

EP - 245

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 4

ER -